Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Avera McKennan Hospital & University Health Center
Agitation and other behavioral disturbances are a main cause in the need for increasing levels of care for the patient with Alzheimer's disease (AD). And while the pathology of dementia has been studied in great detail, the etiology is considered multi-factorial. The hypothesis behind this clinical study is that the presence of the apo lipoprotein E4 (APO E4) allele will serve to predict which patients with late on-set AD are at greater risk to develop agitation.
Age
65–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women who are at least 65 years of age
Meet the DSM-IV-TR criteria for late-onset Alzheimer's Disease (AD)
You may not be if
Unable to provide informed consent or do not have a legally acceptable caregiver and/or representative present or available to enter into the informed consent process on the study subject's behalf
Diagnosis of a non-Alzheimer's type of dementia
Determined by the Principal Investigator (or his designee) that the study subject would be unsuitable for study participation
